ASSOCIATION PRESIDENT
GERALD J. YAKATAN, Ph.D.
GERALD J. YAKATAN, Ph.D.
Founder, Chairman & CEO
IriSys LLC
6628 Nancy Ridge Drive, Suite 100 San Diego, CA, USA
Dr. Yakatan is the founder, Chairman and CEO of IriSys LLC, a company that provides contract services for pharmaceutical product development. Before that, he was the president & CEO of Avanir Pharmaceuticals, San Diego, CA (1998-2005) and Tanabe Research Laboratories, USA, Inc., San Diego, CA (1990 to 1995). He has received numerous awards including ACCP Distinguished Service Award (1996), Philadelphia Chapter APhA Award, etc.
ASSOCIATION VICE PRESIDENT
Hong-Duo Chen
Academician of the Chinese Academy of Engineering
Director, Immunodermatological Key Laboratory, Ministry of Education & Ministry of Health, China
Dr. Hong-Duo Chen, an Academician of Chinese Academy of Engineering, is Professor of Dermatology, Honorary President of No.1 Hospital of China Medical University, Director of Key Laboratory of Immunodermatology of the Ministry of Health, Member of Board of Directors of International Society of Dermatology, President of International Society of Cosmetic Dermatology, Vice-president of International Biomedical Science Association, International Honorary Member of American Dermatological Association, Honorary Member of the American Academy of Dermatology, Honorary Member of Society for Investigative Dermatology, Honorary Member of Japanese Dermatological Association, Honorary Council Member of Asian Dermatological Association.. He has attained the title of “National Advanced Worker”, National May 1 Labor Medals, Wu Jieping Medicine Prize, Meritorious Award for Science and Technology of Liaoning Province, Award for Outstanding Service (International Society of Dermatology) and the ILDS Certificate of Appreciation (International League of Dermatological Societies). He has been awarded the Prize of Science and Technology Progress of Ministry of Health for three times, and so far is the only winner of National Prize for Natural Sciences in dermatology field.
Dr. Dongfeng Tan
Dr. Dongfeng Tan is a full professor and the first physician with Asia-heritage holding joint appointments in two clinical disciplines at University of Texas MD Anderson Cancer Center after he finished a resident and a chief resident at Yale University Medical Center.
Dr. Tan participated in the Human Genome Project at Columbia University in New York. And his research is focused on solid tumors, investigating potential biomarkers to assess survivorship and guide personalized medicine. Dr. Tan has published 200 peer-reviewed scientific articles and book chapters and books which are ‘Principles of Molecular Diagnostics and Personalized Cancer Medicine’ and ‘Advances of Surgical Pathology in Gastric Cancer’, have been translated from English into other language.
He continued as an oncologic pathology fellow at Memorial Sloan-Kettering Cancer Center in New York (1998-1999).
was certified in AP and CP in 1998. He became an assistant professor at Roswell Park Cancer Center in Buffalo (1999-2004). He then worked as an associate professor at the University of Texas Health Center in Houston for two years before I joined MD Anderson Cancer Center in 2006.
Jointly, Dr. Tan has held three patents. He has frequently been invited to present at national and international conferences and seminars. Additionally, he has been invited to chair and co-chair conferences and sections of congresses. Furthermore,
Dr. Tan has mentored numerous residents, fellows, and junior pathologists. As the senior medical consultant of Kingmed Medicine, Dr. Tan introduced ASCP to China in 2014, and he has been the honored director of the ASCP Training Center there. He serves on the CAP Committee of Molecular Marketing Panel.
has also served on the editorial board of eight peer-reviewed journals.
Yong-Xiao Wang, PhD
Yong-Xiao Wang, M.D., Ph.D.
Professor
Albany Medical College
Department of Molecular/Cellular Physiology
Room ME600B6 (Mail Code 8)
47 New Scotland Avenues
Albany, NY 12208
Dr. Yong-Xiao Wang is a Full Professor in the Center for Cardiovascular Sciences at Albany Medical College, USA. He received his postdoctoral training at the Technology University of Munich and University of Pennsylvania. Dr. Wang has been highly successful in his scientific endeavors. As a first author, key contributor and corresponding author, he has had numerous publications in high-impact journals such as Circ Res, Proc Natl Acad Sci U S A, Nature. He has had a number of NIH and other grants as the Principal Investigator.
Jing Liang, MD. PhD.
Professor
Clinical Pharmacy
School of Pharmacy，
University of Southern California
1985 Zonal Ave. Los Angeles, CA, USA
Dr. Liang is a Professor of Clinical Pharmacy at the USC School of Pharmacy, and her team has worked on alcohol use disorder, Alzheimer’s disease, Anxiety disorders, Sleep disorder, and other neurodegenerative diseases. She has published over 70 papers in prestigious journals.
Yi-Han Chen, Cardiologist, Professor, Chief physician. Vice President of Tongji University, Director of Cardiology Department, East Hospital, Tongji University. He received bachelor’s degree in Medicine in 1987, and master’s degree in Internal Medicine in 1992 from Nantong University School of Medicine. In 1996, he was awarded doctoral degree in Cardiac Medicine by Shanghai Jiao Tong University School of Medicine. In 2015, he was elected as academician of the Chinese Academy of Sciences. He reported the first causative gene responsible for human atrial fibrillation; identified a novel biomarker of cardiac pacemaker cells; proposed that cardiac pacemaker cells have the properties of glutamatergic neurons; and discovered the cardiac glutamatergic transmitter system as another cardiac bioelectrical control system.